Journal of Clinical Medicine
Clozapine and Solid Cancer Risk in Lithuania: A Population-Based Cohort Study
By Mingailė Drevinskaitė, Arūnas Germanavičius and Giedrė Smailytė.
Abstract
Background
People with schizophrenia may experience altered cancer risk because of lifestyle-, healthcare access-, and treatment-related factors. Evidence on the solid cancer risk associated with clozapine remains limited. We aimed to assess solid cancer incidence among clozapine users in Lithuania between 2013 and 2021.